Bevacizumab for advanced cervical cancer: Patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
American Journal of Sports Medicine.
Times cited: 45
Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.
Journal of Pediatric Urology.
Times cited: 15